Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Risk stratification in compartmental epidemic models: Where to draw the line?

Suen SC, Goldhaber-Fiebert JD, Brandeau ML.

J Theor Biol. 2017 Sep 7;428:1-17. doi: 10.1016/j.jtbi.2017.06.004. Epub 2017 Jun 9.

PMID:
28606751
2.

Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.

Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML.

PLoS Med. 2017 May 24;14(5):e1002312. doi: 10.1371/journal.pmed.1002312. eCollection 2017 May.

3.

Creating impact with operations research in health: making room for practice in academia.

Brandeau ML.

Health Care Manag Sci. 2016 Dec;19(4):305-312. Epub 2015 May 24.

PMID:
26003321
4.

Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States.

Bernard CL, Brandeau ML, Humphreys K, Bendavid E, Holodniy M, Weyant C, Owens DK, Goldhaber-Fiebert JD.

Ann Intern Med. 2016 Apr 26. doi: 10.7326/M15-2634. [Epub ahead of print]

PMID:
27110953
5.

Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.

Fu R, Gutfraind A, Brandeau ML.

Math Biosci. 2016 Mar;273:102-13. doi: 10.1016/j.mbs.2016.01.003. Epub 2016 Jan 14.

6.

HIV Treatment and Prevention: A Simple Model to Determine Optimal Investment.

Juusola JL, Brandeau ML.

Med Decis Making. 2016 Apr;36(3):391-409. doi: 10.1177/0272989X15598528. Epub 2015 Sep 14.

7.

Optimizing patient treatment decisions in an era of rapid technological advances: the case of hepatitis C treatment.

Liu S, Brandeau ML, Goldhaber-Fiebert JD.

Health Care Manag Sci. 2017 Mar;20(1):16-32. doi: 10.1007/s10729-015-9330-6. Epub 2015 Jul 19.

PMID:
26188961
8.

Expansion of the National Salt Reduction Initiative: A Mathematical Model of Benefits and Risks of Population-Level Sodium Reduction.

Choi SE, Brandeau ML, Basu S.

Med Decis Making. 2016 Jan;36(1):72-85. doi: 10.1177/0272989X15583846. Epub 2015 Apr 29.

9.

Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.

Goldhaber-Fiebert JD, Brandeau ML.

Med Decis Making. 2015 Oct;35(7):818-46. doi: 10.1177/0272989X15583845. Epub 2015 Apr 29. Review.

10.

Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches.

Enns EA, Brandeau ML.

J Theor Biol. 2015 Apr 21;371:154-65. doi: 10.1016/j.jtbi.2015.02.005. Epub 2015 Feb 16.

11.

Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.

Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML.

PLoS One. 2014 Apr 24;9(4):e95735. doi: 10.1371/journal.pone.0095735. eCollection 2014.

12.

Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.

Alistar SS, Owens DK, Brandeau ML.

PLoS One. 2014 Jan 28;9(1):e86584. doi: 10.1371/journal.pone.0086584. eCollection 2014.

13.

Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India.

Goldhaber-Fiebert JD, Brandeau ML.

Med Decis Making. 2015 Feb;35(2):196-210. doi: 10.1177/0272989X13518272. Epub 2014 Jan 29.

14.

Too much of a good thing? When to stop catch-up vaccination.

Hutton DW, Brandeau ML.

Med Decis Making. 2013 Oct;33(7):920-36. doi: 10.1177/0272989X13493142. Epub 2013 Jul 15.

15.

HIV epidemic control-a model for optimal allocation of prevention and treatment resources.

Alistar SS, Long EF, Brandeau ML, Beck EJ.

Health Care Manag Sci. 2014 Jun;17(2):162-81. doi: 10.1007/s10729-013-9240-4. Epub 2013 Jun 23.

16.

Are organic foods safer or healthier?

Smith-Spangler C, Brandeau ML, Olkin I, Bravata DM.

Ann Intern Med. 2013 Feb 19;158(4):297-300. doi: 10.7326/0003-4819-158-4-201302190-00019. No abstract available.

PMID:
23420246
17.

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Cipriano LE, Zaric GS, Holodniy M, Bendavid E, Owens DK, Brandeau ML.

PLoS One. 2012;7(9):e45176. doi: 10.1371/journal.pone.0045176. Epub 2012 Sep 18.

18.

Are organic foods safer or healthier than conventional alternatives?: a systematic review.

Smith-Spangler C, Brandeau ML, Hunter GE, Bavinger JC, Pearson M, Eschbach PJ, Sundaram V, Liu H, Schirmer P, Stave C, Olkin I, Bravata DM.

Ann Intern Med. 2012 Sep 4;157(5):348-66. doi: 10.7326/0003-4819-157-5-201209040-00007. Review. Erratum in: Ann Intern Med. 2012 Oct 2;157(7):532. Ann Intern Med. 2012 Nov 6;157(9):680.

PMID:
22944875
19.

Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal?

Negoescu DM, Owens DK, Brandeau ML, Bendavid E.

Clin Infect Dis. 2012 Nov 15;55(10):1392-9. doi: 10.1093/cid/cis731. Epub 2012 Aug 31.

20.

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Juusola JL, Brandeau ML, Owens DK, Bendavid E.

Ann Intern Med. 2012 Apr 17;156(8):541-50. doi: 10.7326/0003-4819-156-8-201204170-00001.

Supplemental Content

Loading ...
Support Center